We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
11 hedge funds and large institutions have $5.24M invested in ESSA Pharma in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
10% more funds holding
Funds holding: 10 → 11 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.19% less ownership
Funds ownership: 1.88% → 1.7% (-0.19%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
84% less capital invested
Capital invested by funds: $33.1M → $5.24M (-$27.9M)
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
2
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$30.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.8K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.85K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$555 |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$1.15M |
| 2 |
AIC
AWM Investment Company
New York
|
-$419K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$267K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |